Vendor, Boston, MA
Acer Therapeutics Inc.
UEI C6EKP8VELDC1, CAGE 76BR6
2 awards and $0 obligated between March 6, 2024 and May 29, 2026, 100% under full and open competition, against 500.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79725A0022July 7, 2025, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for Miplyffa and OlpruvaNAICS 325412, PSC 6505 | $0 |
| 36F79724D0038March 6, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | 42-A Public Law Permanent Lifecycle Single PricingNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 9 across 2 awards